Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

Barak, 2002, Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer, Proc. Natl. Acad. Sci. USA, 99, 303, 10.1073/pnas.012610299 Behrens, 1996, Functional interaction of beta-catenin with the transcription factor LEF-1, Nature, 382, 638, 10.1038/382638a0 Berger, 2002, Histone modifications in transcriptional regulation, Curr. Opin. Genet. Dev., 12, 142, 10.1016/S0959-437X(02)00279-4 Blaheta, 2002, Anti-tumor mechanisms of valproate, Med. Res. Rev., 22, 492, 10.1002/med.10017 Elbashir, 2001, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 494, 10.1038/35078107 Fodde, 2003, The multiple functions of tumour suppressors, Nat. Cell Biol., 5, 190, 10.1038/ncb0303-190 Fodde, 1994, A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors, Proc. Natl. Acad. Sci. USA, 91, 8969, 10.1073/pnas.91.19.8969 Giles, 2003, Caught up in a Wnt storm, Biochim. Biophys. Acta, 1653, 1 Glass, 2000, The coregulator exchange in transcriptional functions of nuclear receptors, Genes Dev., 14, 121, 10.1101/gad.14.2.121 Göttlicher, 2001, Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells, EMBO J., 20, 6969, 10.1093/emboj/20.24.6969 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 He, 1998, Identification of c-MYC as a target of the APC pathway, Science, 281, 1509, 10.1126/science.281.5382.1509 He, 1999, PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell, 99, 335, 10.1016/S0092-8674(00)81664-5 Hugh, 1999, Beta-Catenin expression in primary and metastatic colorectal carcinoma, Int. J. Cancer, 82, 504, 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6 Janssen, 2002, Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice, Gastroenterology, 123, 492, 10.1053/gast.2002.34786 Jenuwein, 2001, Translating the histone code, Science, 293, 1074, 10.1126/science.1063127 Johnstone, 2002, Histone-deacetylase inhibitors, Nat. Rev. Drug Discov., 1, 287, 10.1038/nrd772 Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1 Korinek, 1997, Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma, Science, 275, 1784, 10.1126/science.275.5307.1784 Krämer, 2001, Histone deacetylase as a therapeutic target, Trends Endocrinol. Metab., 12, 294, 10.1016/S1043-2760(01)00438-6 Krämer, 2003, The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2, EMBO J., 22, 3411, 10.1093/emboj/cdg315 Lagger, 2002, Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression, EMBO J., 21, 2672, 10.1093/emboj/21.11.2672 Laird, 1995, Suppression of intestinal neoplasia by DNA hypomethylation, Cell, 81, 197, 10.1016/0092-8674(95)90329-1 Marks, 2001, Histone deacetylases and cancer, Nat. Rev. Cancer, 1, 194, 10.1038/35106079 Melnick, 2002, Histone deacetylases as therapeutic targets in hematologic malignancies, Curr. Opin. Hematol., 9, 322, 10.1097/00062752-200207000-00010 Molenaar, 1996, XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos, Cell, 86, 391, 10.1016/S0092-8674(00)80112-9 Monteiro, 2000, BRCA1, Trends Biochem. Sci., 25, 469, 10.1016/S0968-0004(00)01632-7 Morin, 1999, Beta-Catenin signaling and cancer, Bioessays, 21, 1021, 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P Morin, 1996, Apoptosis and APC in colorectal tumorigenesis, Proc. Natl. Acad. Sci. USA, 93, 7950, 10.1073/pnas.93.15.7950 Park, 2001, Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells, Proc. Natl. Acad. Sci. USA, 98, 2598, 10.1073/pnas.051630998 Phiel, 2001, Molecular targets of lithium action, Annu. Rev. Pharmacol. Toxicol., 41, 789, 10.1146/annurev.pharmtox.41.1.789 Phiel, 2001, Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen, J. Biol. Chem., 276, 36734, 10.1074/jbc.M101287200 Remiszewski, 2002, Recent advances in the discovery of small molecule histone deacetylase inhibitors, Curr. Opin. Drug Discov. Dev., 5, 487 Scully, 2001, Interactions between BRCA proteins and DNA structure, Exp. Cell Res., 264, 67, 10.1006/excr.2000.5132 Sears, 1999, Ras enhances Myc protein stability, Mol. Cell, 3, 169, 10.1016/S1097-2765(00)80308-1 Shoemaker, 1997, Studies of neoplasia in the Min mouse, Biochim. Biophys. Acta, 1332, F25 Shtutman, 1999, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway, Proc. Natl. Acad. Sci. USA, 96, 5522, 10.1073/pnas.96.10.5522 Stambolic, 1996, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells, Curr. Biol., 6, 1664, 10.1016/S0960-9822(02)70790-2 Strahl, 2000, The language of covalent histone modifications, Nature, 403, 41, 10.1038/47412 Su, 1992, Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene, Science, 256, 668, 10.1126/science.1350108 Tetsu, 1999, beta-Catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, 398, 422, 10.1038/18884 Valizadeh, 1997, Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps, Am. J. Pathol., 150, 1977 van de Wetering, 2002, The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells, Cell, 111, 241, 10.1016/S0092-8674(02)01014-0 Varambally, 2002, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, 419, 624, 10.1038/nature01075 Verdin, 2003, Class II histone deacetylases, Trends Genet., 19, 286, 10.1016/S0168-9525(03)00073-8 Yang, 1996, Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3, Proc. Natl. Acad. Sci. USA, 93, 12845, 10.1073/pnas.93.23.12845 Yang, 1997, Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family, J. Biol. Chem., 272, 28001, 10.1074/jbc.272.44.28001 Zeng, 1998, Cloning and characterization of the mouse histone deacetylase-2 gene, J. Biol. Chem., 273, 28921, 10.1074/jbc.273.44.28921 Zhang, 2002, Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy, Cell, 110, 479, 10.1016/S0092-8674(02)00861-9